Literature DB >> 4026270

Systemic absorption and persistence of tioconazole in vaginal fluid after insertion of a single 300-mg tioconazole ovule.

E T Houang, A G Lawrence.   

Abstract

After vaginal insertion of a 300-mg ovule of tioconazole in 10 patients with vaginal candidiasis, the mean concentration in plasma was 21.2 ng/ml (range, 10.6 to 35.8 ng/ml) at 8 h and was not measurable at 24 h in 9 of 10 patients. The mean vaginal concentration at 24 h was 21.4 mg/liter (range, 2.4 to 50 mg/liter) and remained detectable in 7 of 9 and 2 of 9 patients after 48 and 72 h, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026270      PMCID: PMC180197          DOI: 10.1128/AAC.27.6.964

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Quality control of serum gentamicin assays--experience of national surveys.

Authors:  D S Reeves; M J Bywater
Journal:  J Antimicrob Chemother       Date:  1975-03       Impact factor: 5.790

2.  Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.

Authors:  S Jevons; G E Gymer; K W Brammer; D A Cox; M R Leeming
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

  2 in total
  3 in total

1.  Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis.

Authors:  G E Stein; D Gurwith; N Mummaw; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.